| Stephen P Tarpy, MD | |
|
541 Main St Ste 314, South Weymouth, MA 02190-1857 | |
| (781) 952-1460 | |
| Not Available |
| Full Name | Stephen P Tarpy |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 38 Years |
| Location | 541 Main St Ste 314, South Weymouth, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497705065 | NPI | - | NPPES |
| 3099628 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 059299 (Massachusetts) | Secondary |
| 207R00000X | Internal Medicine | 059299 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Shore Hospital | South weymouth, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harbor Medical Associates Inc | 2466356209 | 237 |
News Archive
In recognition of her ongoing support of the nation's human spaceflight program, U.S. Senator Kay Bailey Hutchison is the 2012 recipient of the National Space Biomedical Research Institute's (NSBRI) Pioneer Award.
Flint residents will soon be able to participate in a voluntary registry that will help connect them to programs designed to minimize the effects of lead on their health.
Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.
Doxorubicin (Dox) is an effective anti-cancer drug, but it's also a very toxic one, causing severe heart and immune damage. The doses needed to impact tumors are not well tolerated by patients, however, researchers may have found an answer through combination therapy.
› Verified 1 days ago
| Entity Name | Harbor Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124079561 PECOS PAC ID: 2466356209 Enrollment ID: O20040719000954 |
News Archive
In recognition of her ongoing support of the nation's human spaceflight program, U.S. Senator Kay Bailey Hutchison is the 2012 recipient of the National Space Biomedical Research Institute's (NSBRI) Pioneer Award.
Flint residents will soon be able to participate in a voluntary registry that will help connect them to programs designed to minimize the effects of lead on their health.
Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.
Doxorubicin (Dox) is an effective anti-cancer drug, but it's also a very toxic one, causing severe heart and immune damage. The doses needed to impact tumors are not well tolerated by patients, however, researchers may have found an answer through combination therapy.
› Verified 1 days ago
| Entity Name | Coastal Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932175684 PECOS PAC ID: 7113029257 Enrollment ID: O20070221000057 |
News Archive
In recognition of her ongoing support of the nation's human spaceflight program, U.S. Senator Kay Bailey Hutchison is the 2012 recipient of the National Space Biomedical Research Institute's (NSBRI) Pioneer Award.
Flint residents will soon be able to participate in a voluntary registry that will help connect them to programs designed to minimize the effects of lead on their health.
Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.
Doxorubicin (Dox) is an effective anti-cancer drug, but it's also a very toxic one, causing severe heart and immune damage. The doses needed to impact tumors are not well tolerated by patients, however, researchers may have found an answer through combination therapy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen P Tarpy, MD 541 Main St Ste 314, South Weymouth, MA 02190-1857 Ph: (781) 952-1460 | Stephen P Tarpy, MD 541 Main St Ste 314, South Weymouth, MA 02190-1857 Ph: (781) 952-1460 |
News Archive
In recognition of her ongoing support of the nation's human spaceflight program, U.S. Senator Kay Bailey Hutchison is the 2012 recipient of the National Space Biomedical Research Institute's (NSBRI) Pioneer Award.
Flint residents will soon be able to participate in a voluntary registry that will help connect them to programs designed to minimize the effects of lead on their health.
Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.
Doxorubicin (Dox) is an effective anti-cancer drug, but it's also a very toxic one, causing severe heart and immune damage. The doses needed to impact tumors are not well tolerated by patients, however, researchers may have found an answer through combination therapy.
› Verified 1 days ago
Ching Chan Reisig, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Rd # 73, South Weymouth, MA 02190 Phone: 781-624-8000 | |
Dr. Paul J. Schubert, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 541 Main St, Suite 400, South Weymouth, MA 02190 Phone: 781-952-1200 Fax: 781-340-1610 | |
Clayland F Cox, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1085 Main St, South Weymouth, MA 02190 Phone: 781-331-2922 | |
Aboualkheir Alzaim, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 540 Main St, South Weymouth, MA 02190 Phone: 781-340-6420 Fax: 781-340-6421 | |
Dr. Anahita Ghorbani, M.D., M.P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 541 Main St Ste 400, South Weymouth, MA 02190 Phone: 781-952-1460 Fax: 781-340-1610 | |
Dr. Shail Maingi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Columbian St, South Weymouth, MA 02190 Phone: 518-525-5634 | |
Jessica E Viola, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Rd, South Shore Hospital, South Weymouth, MA 02190 Phone: 781-624-8000 |